Lossius Morten I, Rønning Ole M, Slapø Geir D, Mowinckel Petter, Gjerstad Leif
National Centre for Epilepsy, Sandvika, Norway.
Epilepsia. 2005 Aug;46(8):1246-51. doi: 10.1111/j.1528-1167.2005.57904.x.
The aims of the study were to assess the occurrence of poststroke epilepsy (PSE) in patients with ischemic strokes, to identify predictors, and to investigate whether treatment in a stroke unit (SU) influenced the long-term outcomes of epilepsy.
Patients with PSE, defined as those having two ore more unprovoked epileptic seizures > or = 1 week after an ischemic stroke, were identified from a cohort of 484 patients with ischemic strokes. The patients were prospectively assessed 7-8 years after stroke or until death. Different variables were studied to look for possible predictors.
From 484 patients with ischemic strokes, PSE developed in 12 (2.5%) and 15 (3.1%) patients during the first year and 7-8 years after stroke, respectively. Eight (53%) of these patients were treated in a stroke unit (SU), and seven (47%) were treated in a general medical ward (GMW). The mean age of those who developed PSE and those who did not was 74.3 years and 76.3 years, respectively. In a multivariate analysis, a Scandinavian Stroke Scale (SSS) score < 30 on admission was a significant predictor for developing PSE [odds ratio (OR), 4.9; p = 0.004).
The prevalence of PSE, 7 to 8 years after an ischemic stroke, was 3.1%. SSS scores < 30 on admission were a significant predictor for PSE. Neither treatment in SU versus GMW, cortical location, nor age at onset of stroke seemed to influence the risk of developing PSE.
本研究旨在评估缺血性卒中患者中风后癫痫(PSE)的发生率,确定预测因素,并调查在卒中单元(SU)进行治疗是否会影响癫痫的长期预后。
从484例缺血性卒中患者队列中识别出PSE患者,定义为在缺血性卒中后≥1周出现两次或更多次无诱因癫痫发作的患者。对患者在卒中后7 - 8年进行前瞻性评估,直至死亡。研究不同变量以寻找可能的预测因素。
在484例缺血性卒中患者中,分别有12例(2.5%)和15例(3.1%)在卒中后第1年和7 - 8年发生PSE。这些患者中有8例(53%)在卒中单元(SU)接受治疗,7例(47%)在普通内科病房(GMW)接受治疗。发生PSE的患者和未发生PSE的患者的平均年龄分别为74.3岁和76.3岁。多因素分析显示,入院时斯堪的纳维亚卒中量表(SSS)评分<30是发生PSE的显著预测因素[比值比(OR),4.9;p = 0.004]。
缺血性卒中后7至8年PSE的患病率为3.1%。入院时SSS评分<30是PSE的显著预测因素。在SU与GMW接受治疗、皮质部位以及卒中发病年龄似乎均不影响发生PSE的风险。